Stock data
Perspective Therapeutics, Inc. (CATX)
Perspective Therapeutics, Inc. (CATX) reported net income of -US$103.12M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$113.56M | -US$103.12M | — |
| 2024 | — | — | -US$90.89M | -US$79.28M | — |
| 2023 | — | US$1.43M | -US$40.94M | -US$46.51M | — |
| 2022 | — | US$0.00M | -US$8.67M | -US$10.76M | — |
| 2021 | — | US$5.12M | -US$3.45M | -US$3.39M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$26.79M | — |
| 2026-03-31 | — | -US$26.19M | — |
| 2025-12-31 | — | -US$37.49M | — |
| 2025-09-30 | — | -US$25.97M | — |
| 2025-06-30 | — | -US$21.48M | — |
| 2025-03-31 | — | -US$18.18M | — |
| 2024-12-31 | — | -US$40.17M | — |
| 2024-09-30 | — | -US$15.12M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.